Venous thromboembolism is a serious healthcare problem affecting over 1 in 1000 adults worldwide annually. Epidemiological studies have shown that before the use of thromboprophylaxis in hospital, 55-60% of all venous thromboembolisms were related to hospital admission, occurring either in hospital or within 90 days after discharge.
Sex matters when it comes to venous thromboembolism (VTE). We defined 5P's - period, pill, prognosis, pregnancy, and post-thrombotic syndrome - that should be discussed with young women with VTE. Menstrual blood
loss (Period) can be aggravated by anticoagulant therapy. This seems particularly true for direct oral anticoagulants.
British Society for Haematology (BSH) have put together a playlist of interviews with 23 expert speaker videos on Youtube which may be of interest to Thrombosis UK members.
Evidence-based recommendations on percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg in adults. This involves removing the clot through a catheter inserted into the vein.
The 2018 updated National Institute for Health and Care Excellence (NICE) guidance on venous thromboembolism (VTE) (NICE 2018)includes significant changes and extensions to the 2010 guidance on VTE risk assessment and thromboprophylaxis for hospital patients (NICE 2010).
LONDON, JUNE 7, 2019 — Thrombosis UK and the International Society on Thrombosis and Haemostasis (ISTH) welcome today’s announcement by Her Majesty the Queen that Professor Beverley Hunt
has been awarded an Officer of the Most Excellence Order of the British Empire in the Queen’s Birthday Honours List 2019. The award recognizes Hunt’s service to medicine.
Human immunodeficiency virus (HIV) infection remains one of the biggest health burdens worldwide, affecting 36.9 million people (World Health Organisation, 2017). Venous thromboembolism (VTE) has a reported incidence of 0.19–7.63% in those with HIV, representing a 2–10 fold increase compared to the general population (Bibas et al, 2011; Rasmussen et al, 2011).
We are writing to express our collective concern about the recommendation in the National Institute for Health and Care Excellence (NICE) guideline [NG89].
The Northern Care Alliance NHS Group has launched a new electronic risk assessment for all forms of blot clots as part of its Global Digital Exemplar (GDE) fast follower programme.